EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evidence for dysfunctional gut permeability in preclinical models of autism

Yuansong Li, Subhomitra Saha, Gabrielle T. Belz, Steve Petrovski, Ashley E. Franks, Elisa Hill-Yardin

Brain, Behavior, & Immunity - Health · 2026-11 · 101400

DOI: 10.1016/j.bbih.2026.101400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, & Immunity - Health, 2026-11. Verfasst von Yuansong Li und 5 weiteren Autor:innen. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) issues are frequently reported by individuals with autism spectrum disorder (autism) or their caregivers, yet biological mechanisms underlying these symptoms remain incompletely understood. Increasing evidence suggests that impaired intestinal barrier integrity is a recurrent feature of autism and may contribute to both gastrointestinal and behavioural phenotypes observed in preclinical mouse models; however, comparisons across preclinical autism models are limited. Here, we compare findings from five well-established preclinical models of autism that have been widely used to study both gastrointestinal and neurobehavioural features, including the maternal immune activation (MIA) and early-life immune activation (EIA) models, the Black and Tan Brachyury (BTBR T+tf/J) phenotype-first strain, Shank3 deletion ( Shank3αβ and Shank3B -/- ), Neuroligin-3 R451C ( Nlgn3 R451C ), and chromodomain helicase DNA-binding protein 8 haploinsufficient ( Chd8 +/- ) mice. Across these models, we highlight increased gut permeability, disrupted tight junctions and/or mucus barrier composition, immune dysregulation, and altered enteric nervous system structure or function, particularly in models such as BTBR T+tf/J mice and mice expressing the R451C variant in the Nlgn3 gene. The potential involvement of neuro-immune mechanisms, including interactions of the neuropeptide vasoactive intestinal peptide (VIP) with type 3 innate lymphoid cells (ILC3s) and the cytokine interleukin-22 (IL-22), and their contribution to gut barrier dysfunction reported in a variety of autism-related models is also discussed. Despite distinct genetic or environmental aetiologies, these models reveal recurring alterations across epithelial, immune, microbial and enteric neuronal systems, although heterogeneity in mechanisms associated with intestinal barrier dysfunction are likely present.

Zitieren

APA

Li, Y., Saha, S., Belz, G. T., Petrovski, S., Franks, A. E., & Hill-Yardin, E. (2026). Evidence for dysfunctional gut permeability in preclinical models of autism. Brain, Behavior, & Immunity - Health, 101400. https://doi.org/10.1016/j.bbih.2026.101400

Vancouver

Li Y, Saha S, Belz GT, Petrovski S, Franks AE, Hill-Yardin E. Evidence for dysfunctional gut permeability in preclinical models of autism. Brain, Behavior, & Immunity - Health. 2026:101400. doi:10.1016/j.bbih.2026.101400

BibTeX
@article{Li2026,
  author = {Li, Yuansong and Saha, Subhomitra and Belz, Gabrielle T. and Petrovski, Steve and Franks, Ashley E. and Hill-Yardin, Elisa},
  title = {Evidence for dysfunctional gut permeability in preclinical models of autism},
  journal = {Brain, Behavior, & Immunity - Health},
  year = {2026},
  pages = {101400},
  doi = {10.1016/j.bbih.2026.101400}
}
Kostenlos starten →